{"schema_version":"secwatch.filing_event.v1","accession":"0001566469-23-000059","form_type":"8-K","ticker":null,"cik":"0001566469","company_name":"NantHealth, Inc.","filed_at":"2023-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.361881+00:00","generated_at":"2026-06-10T19:03:20.995059+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NantHealth appoints Rao Haris Naseem as CEO; Patrick Soon-Shiong remains Chairman","bullets":["Dr. Rao Haris Naseem appointed CEO and board member effective September 7, 2023.","Founder Patrick Soon-Shiong steps down as CEO but continues as Chairman.","Base salary set at $35,568; eligible for discretionary bonus; option to purchase 1,000,000 shares subject to board approval.","Naseem's affiliate Summus Holdings purchased 3,846,154 shares ($1.5M) in a private placement closed August 30, 2023.","Employment is at-will; vesting of stock options accelerated 100% upon change in control."],"urls":{"canonical":"https://secwatch.observer/filing/0001566469-23-000059","json":"https://secwatch.observer/filing/0001566469-23-000059.json","markdown":"https://secwatch.observer/filing/0001566469-23-000059.md","text":"https://secwatch.observer/filing/0001566469-23-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566469/000156646923000059/0001566469-23-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566469/000156646923000059/nh-20230907.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T19:03:20.995059+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bd9f74f9b8","claim":"Patrick Soon-Shiong changed role as Chairman of the Board at NantHealth, Inc..","evidence_excerpt":"In connection with Dr. Naseem’s appointment as CEO, Patrick Soon-Shiong, M.D. transitioned out of his role as CEO of the Company and will continue to serve as Chairman of the Board as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1566469/000156646923000059/0001566469-23-000059-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned out of CEO role"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"ece7289f7b","claim":"Rao Haris Naseem was appointed as Chief Executive Officer at NantHealth, Inc..","evidence_excerpt":"On September 7, 2023, the Board of Directors (the “Board”) of NantHealth, Inc. (the “Company”) appointed Rao Haris Naseem, M.D., FACC, FHRS as the Company’s Chief Executive Officer (“CEO”) and a member of the Board, effective September 7, 2023 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1566469/000156646923000059/0001566469-23-000059-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}